SAFETY AND EFFICACY OF LENTIGLOBIN GENE THERAPY IN PATIENTS...

HemaSphere 2019 / 06 Vol. 3

SAFETY AND EFFICACY OF LENTIGLOBIN GENE THERAPY IN PATIENTS WITH TRANSFUSION-DEPENDENT B-THALASSAEMIA AND NON-B0/B0 GENOTYPES IN THE PHASE 3 NORTHSTAR-2 STUDY

Locatelli, F., Thompson, A. A., Hongeng, S., Porter, J. B., Sauer, M. G., Kwiatkowski, J. L., Thrasher, A. J., Thuret, I., Elliot, H., Tao, G., Colvin, R. A., Walters, M. C.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
3
Journal:
HemaSphere
DOI:
10.1097/01.hs9.0000564776.92239.40
Date:
June, 2019
File:
PDF, 194 KB
2019
Conversion to is in progress
Conversion to is failed